Journal of Radiation Research and Radiation Proces ›› 2016, Vol. 34 ›› Issue (1): 10101-010101.doi: 10.11889/j.1000-3436.2016.rrj.34.010101

• REVIEW •     Next Articles

Review on molecular mechanisms and protective drugs research on radiation-induced lung fibrosis

ZHENG Qisheng  LIU Peixun   

  1. (Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine,
    Peking Union Medical College & Chinese Academy of Medical Science, Tianjin 300192, China)
  • Received:2015-09-30 Revised:2015-11-18 Online:2016-02-20 Published:2015-12-07
  • Contact: LIU Peixun, professor E-mail:liupeixun@irm-cams.ac.cn
  • About author:ZHENG Qisheng, male, was born in March 1989 and graduated from Jinggangshan University in 2013. Now he is a master candidate in Peking Union Medical College
  • Supported by:

    Supported by Peking Union Medical College Peking Union Youth Innovation Fund (1568) and the Institute of Radiation Medicine, Academy of Medicine Science Discovery Foundation (1560)

Abstract:

The current understanding of the cells, cytokines, and the key factors linked to the signaling networks implicated in RILF were summarized. Targets with potential therapeutic effects for the treatment of RILF were also be discussed and listed. From all above, we hope to provide researchers with ideas in studying the drugs with prevention and (or) the treatment of RILF.

CLC Number: 

  • R979.6,R818